Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

2.14
Delayed Data
As of 12:53pm ET
 +0.07 / +3.38%
Today’s Change
1.90
Today|||52-Week Range
5.43
-25.17%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close2.07
Today’s open2.12
Day’s range2.09 - 2.17
Volume19,875
Average volume (3 months)106,589
Market cap$38.3M
Dividend yield--
Data as of 12:53pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-51.11%
Earnings growth (this year)+4.41%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.74

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd-0.00-0.01%
--Protea Biosciences G...-0.01-2.50%
AEZSAEterna Zentaris Inc+0.08+2.81%
ZYNEZynerba Pharmaceutic...+0.45+7.59%
Data as of 1:16pm ET, 02/12/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$9.2M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating Officer &
Director
Uri Yablonka
Corporate headquarters
Hackensack, New Jersey

Forecasts

Partner Offers